Arrest of B16 melanoma cells in the mouse pulmonary microcirculation induces endothelial nitric oxide synthase-dependent nitric oxide release that is cytotoxic to the tumor cells.

Metastatic cancer cells seed the lung via blood vessels. Because endothelial cells generate nitric oxide (NO) in response to shear stress, we postulated that the arrest of cancer cells in the pulmonary microcirculation causes the release of NO in the lung. After intravenous injection of B16F1 melanoma cells, pulmonary NO increased sevenfold throughout 20 minutes and approached basal levels by 4 hours. NO induction was blocked by N(G)-nitro-L-arginine methyl ester (L-NAME) and was not observed in endothelial nitric oxide synthase (eNOS)-deficient mice. NO production, visualized ex vivo with the fluorescent NO probe diaminofluorescein diacetate, increased rapidly at the site of tumor cell arrest, and continued to increase throughout 20 minutes. Arrested tumor cells underwent apoptosis with apoptotic counts more than threefold over baseline at 8 and 48 hours. Neither the NO signals nor increased apoptosis were seen in eNOS knockout mice or mice pretreated with L-NAME. At 48 hours, 83% of the arrested cells had cleared from the lungs of wild-type mice but only approximately 55% of the cells cleared from eNOS-deficient or L-NAME pretreated mice. eNOS knockout and L-NAME-treated mice had twofold to fivefold more metastases than wild-type mice, measured by the number of surface nodules or by histomorphometry. We conclude that tumor cell arrest in the pulmonary microcirculation induces eNOS-dependent NO release by the endothelium adjacent to the arrested tumor cells and that NO is one factor that causes tumor cell apoptosis, clearance from the lung, and inhibition of metastasis.

[1]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[2]  I. Fidler,et al.  Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. , 1991, Cancer research.

[3]  J. Beckman,et al.  Superoxide Reacts with Nitric Oxide to Nitrate Tyrosine at Physiological pH via Peroxynitrite* , 2000, The Journal of Biological Chemistry.

[4]  T. Ohhashi,et al.  Acetylcholine- and flow-induced production and release of nitric oxide in arterial and venous endothelial cells. , 1996, The American journal of physiology.

[5]  R. Korthuis,et al.  Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules , 1996, Clinical & Experimental Metastasis.

[6]  I. Fidler,et al.  Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages. , 2000, Cancer research.

[7]  H. Maeda,et al.  Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth , 1996, Cancer.

[8]  John Calvin Reed,et al.  Anti-cell death activity promotes pulmonary metastasis of melanoma cells , 1997, Oncogene.

[9]  A. Al-Mehdi,et al.  Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.

[10]  X. Le,et al.  Genetic disruption of host nitric oxide synthase II gene impairs melanoma‐induced angiogenesis and suppresses pleural effusion , 2001, International journal of cancer.

[11]  I. Hart,et al.  Biology of tumour metastasis , 1992, The Lancet.

[12]  T. Whiteside,et al.  Therapeutic Activity of NK Cells against Tumors , 2001, International reviews of immunology.

[13]  F. Vidal-Vanaclocha,et al.  Sinusoidal endothelium release of hydrogen peroxide enhances very late antigen‐4‐mediated melanoma cell adherence and tumor cytotoxicity during interleukin‐1 promotion of hepatic melanoma metastasis in mice , 1997, Hepatology.

[14]  A. Al-Mehdi,et al.  Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. , 1998, Circulation research.

[15]  V. Schirrmacher,et al.  Nitric oxide-induced apoptosis in tumor cells. , 2001, Advances in cancer research.

[16]  A. Santoni,et al.  Natural killer cells and nitric oxide. , 2001, International immunopharmacology.

[17]  A. Seiyama,et al.  Increase in experimental pulmonary metastasis in mice by L‐arginine under inhibition of nitric oxide production by NG‐nitro‐L‐arginine methyl ester , 1998, International journal of cancer.

[18]  F. Orr,et al.  Increased expression of activated matrix metalloproteinase-2 by human endothelial cells after sublethal H2O2 exposure. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[19]  J. Abbruzzese,et al.  Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. , 2001, Cancer research.

[20]  F. Orr,et al.  Tumor cell interactions with the microvasculature: a rate-limiting step in metastasis. , 2001, Surgical oncology clinics of North America.

[21]  A. Al-Mehdi,et al.  Ca2+- and Phosphatidylinositol 3-Kinase-dependent Nitric Oxide Generation in Lung Endothelial Cells in Situ with Ischemia* , 2000, The Journal of Biological Chemistry.

[22]  F. Orr,et al.  Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: effects of interleukin-1alpha on metastasis and the location of B16F1 melanoma cell arrest. , 1997, Cancer research.

[23]  U. Bagge,et al.  Lethal deformation of cancer cells in the microcirculation: A potential rate regulator of hematogenous metastasis , 1992, International journal of cancer.

[24]  J. Carretero,et al.  Tumoricidal Activity of Endothelial Cells , 2001, The Journal of Biological Chemistry.

[25]  J. Jessup,et al.  Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis. , 2001, The American journal of pathology.

[26]  Simon C Watkins,et al.  Reactive nitrogen and oxygen radicals formed during hepatic ischemia-reperfusion kill weakly metastatic colorectal cancer cells. , 1999, Cancer research.

[27]  D. Nance,et al.  Regulation of B16F1 melanoma cell metastasis by inducible functions of the hepatic microvasculature. , 2002, European journal of cancer.

[28]  I. Christensen,et al.  Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  G. Yang,et al.  Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model , 1999, Gene Therapy.

[30]  Z. Dong,et al.  Adenovirus-mediated interferon-β gene therapy suppresses growth and metastasis of human prostate cancer in nude mice , 2001, Cancer Gene Therapy.

[31]  J. Laman,et al.  Functional and in situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  Christopher W. Wong,et al.  Apoptosis: an early event in metastatic inefficiency. , 2001, Cancer research.

[33]  Y. Soini,et al.  Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.